Litcius/Paper detail

Cumulative Adverse Event Reporting of Anaphylaxis After mRNA COVID-19 Vaccine (Pfizer-BioNTech) Injections in Japan: The First-Month Report

Toyotaka Iguchi, Hikari Umeda, Michie Kojima, Yuri Kanno, Yuta Tanaka, Natsumi Kinoshita, Daisaku Sato

2021Drug Safety34 citationsDOIOpen Access PDF

Topics & Concepts

MedicineCoronavirus disease 2019 (COVID-19)AnaphylaxisAdverse effect2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PediatricsVirologyAnesthesiaInternal medicineImmunologyAllergyOutbreakDiseaseInfectious disease (medical specialty)COVID-19 Impact on ReproductionSARS-CoV-2 and COVID-19 ResearchDermatological and COVID-19 studies
Cumulative Adverse Event Reporting of Anaphylaxis After mRNA COVID-19 Vaccine (Pfizer-BioNTech) Injections in Japan: The First-Month Report | Litcius